Skip to main content

Table 2 Ongoing CVOT for GLP-1 RAs

From: Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Drug

CVOT (ClinicalTrial.gov ID)

n

Estimated completion date

Exenatide QW

EXSCEL (NCT01144338)

14,000

2018

Dulaglutide

REWIND (NCT01394952)

9622

2019

Albiglutide

HARMONY outcomes (NCT02465515)

9400

2019

  1. Data in table derived from ClinicalTrials.gov
  2. CVOT cardiovascular outcome trial, GLP-1 RA glucagon-like peptide-1 receptor agonist, QW once weekly
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840